MilliporeSigma Reorganizes And Adopts New Operating Model | Contract Pharma
.png "Merck opens latest 2,700 square metre commercial facility in France")
Merck opens latest 2,700 square metre commercial facility in France
Dirk T. Lange on LinkedIn: Today marks a new chapter for me as I join an organization with so much… | 209 comments
Q&A: Dirk Lange, president and CEO of KBI Biopharma, talks about biotech growth in The Woodlands | Community Impact
Équipe dirigeante
Équipe dirigeante
Dirk Lange email address & phone number | MilliporeSigma EVP, Global Head of Life Science Services at MilliporeSigma contact information - RocketReach
Dirk T. Lange on LinkedIn: Biologics Testing Center Shanghai - News | Merck KGaA, Darmstadt, Germany
Merck increases global commitment to biosafety testing with €35 million investment in Scotland | Glasgow Chamber of Commerce
Dirk T. Lange - MilliporeSigma | LinkedIn
Merck Life Science on X: "The battle against cancer is long and arduous. However, HPAPIs, or Highly Potent Active Pharmaceutical Ingredients, can be a powerful weapon against cancer. Hear from our Head
Dirk T. Lange - MilliporeSigma | LinkedIn
Dirk T. Lange - MilliporeSigma | LinkedIn
Dirk T. Lange - MilliporeSigma | LinkedIn
MilliporeSigma opens 70,000 square foot expansion in Verona | Madison365
CDMO : Merck va doubler sa production d'HPAPI aux États-Unis
Dirk T. Lange on LinkedIn: One of our strategic priorities continues to be strengthening our…
Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma
Dirk Lange
Dirk T. Lange on LinkedIn: Today marks a new chapter for me as I join an organization with so much… | 209 comments
MilliporeSigma To Invest More Than $286M In Biosafety Testing Capacity | Contract Pharma
Équipe dirigeante
Say hello to a “CTDMO” - Molecule to Market
Latest news and insights on the pharmaceutical industry | Indian Pharma Post
Santé : Merck, le géant allemand qui parie gros sur la France et la Gironde
Dirk Lange
Merck KGaA forms new life sciences unit in push to strengthen its CDMO position | Fierce Pharma
